KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease

Measuring inconsistency in meta-analyses

Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works

RoB 2: a revised tool for assessing risk of bias in randomised trials

Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 33,583 · see citing works

A New Equation to Estimate Glomerular Filtration Rate

Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603 · see citing works

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · see citing works

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189 · see citing works

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638 · see citing works

Dapagliflozin in Patients with Chronic Kidney Disease

Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618 · see citing works

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051 · see citing works

New creatinine- and cystatin C-based equations to estimate GFR without race

Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102953 · Cited by 4,695 · see citing works

Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango)

Charles, C., Gafni, A., & Whelan, T. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00221-3 · Cited by 4,137 · see citing works

Estimating glomerular filtration rate from serum creatinine and cystatin C

Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Van Lente, F., Zhang, Y. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114248 · Cited by 4,102 · see citing works

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline

Stevens, P. E., Levin, A., & for the Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00007 · Cited by 3,607 · see citing works

Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes

Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Nowack, C., Schloemer, P., Joseph, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2025845 · Cited by 2,935 · see citing works

Mortality in relation to smoking: 50 years' observations on male British doctors

Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · see citing works

Empagliflozin in Patients with Chronic Kidney Disease

The EMPA-KIDNEY Collaborative Group (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2204233 · Cited by 2,754 · see citing works

GRADE guidelines 6. Rating the quality of evidence—imprecision

Guyatt, G. H., Oxman, A. D., Kunz, R., Brozek, J., Alonso-Coello, P., Rind, D., Devereaux, P. J., Montori, V. M., Freyschuss, B., Vist, G., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.01.012 · Cited by 2,693 · see citing works

Colchicine in Patients with Chronic Coronary Disease

Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., The, S. H. K., Xu, X.-F., Ireland, M. A., Lenderink, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021372 · Cited by 2,299 · see citing works

ROBIS: A new tool to assess risk of bias in systematic reviews was developed

Whiting, P., Savović, J., Higgins, J. P. T., Caldwell, D. M., Reeves, B. C., Shea, B., Davies, P., Kleijnen, J., & Churchill, R. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.06.005 · Cited by 2,272 · see citing works

KDOQI clinical practice guideline for nutrition in CKD: 2020 update

Ikizler, T. A., Burrowes, J. D., Byham-Gray, L. D., Campbell, K. L., Carrero, J.-J., Chan, W., Fouque, D., Friedman, A. N., Ghaddar, S., Goldstein-Fuchs, D. J., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.006 · Cited by 1,960 · see citing works

Interpretation of the evidence for the efficacy and safety of statin therapy

Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857 · see citing works

Cardiovascular events with finerenone in kidney disease and type 2 diabetes

Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110956 · Cited by 1,814 · see citing works

Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms

Vyas, D. A., Eisenstein, L. G., & Jones, D. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmms2004740 · Cited by 1,731 · see citing works

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Sattar, N., Lee, M. M. Y., Kristensen, S. L., Branch, K. R. H., Del Prato, S., Khurmi, N. S., Lam, C. S. P., Lopes, R. D., McMurray, J. J. V., Pratley, R. E., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00203-5 · Cited by 1,599 · see citing works

Chronic Kidney Disease: Effects on the Cardiovascular System

Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448 · see citing works

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab777 · Cited by 1,317 · see citing works

Development and validation of the American Heart Association’s PREVENT equations

Khan, S. S., Matsushita, K., Sang, Y., Ballew, S. H., Grams, M. E., Surapaneni, A., Blaha, M. J., Carson, A. P., Chang, A. R., Ciemins, E., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067626 · Cited by 1,234 · see citing works

Sex Differences in Pharmacokinetics and Pharmacodynamics

Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163 · see citing works

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

Baigent, C., Emberson, J., Haynes, R., Herrington, W. G., Judge, P., Landray, M. J., Mayne, K. J., Ng, S. Y. A., Preiss, D., Roddick, A. J., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02074-8 · Cited by 1,020 · see citing works

Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association

Khan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001191 · Cited by 797 · see citing works

Effect of salt substitution on cardiovascular events and death

Neal, B., Wu, Y., Feng, X., Zhang, R., Zhang, Y., Shi, J., Zhang, J., Tian, M., Huang, L., Li, Z., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105675 · Cited by 742 · see citing works

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

Tangri, N., Grams, M. E., Levey, A. S., Coresh, J., Appel, L. J., Astor, B. C., Chodick, G., Collins, A. J., Djurdjev, O., Elley, C. R., et al. (2016) · JAMA · doi:10.1001/jama.2015.18202 · Cited by 737 · see citing works

ESPEN practical guideline: Clinical nutrition and hydration in geriatrics

Volkert, D., Beck, A. M., Cederholm, T., Cruz-Jentoft, A., Hooper, L., Kiesswetter, E., Maggio, M., Raynaud-Simon, A., Sieber, C., Sobotka, L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.01.024 · Cited by 516 · see citing works

Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Clase, C. M., Carrero, J.-J., Ellison, D. H., Grams, M. E., Hemmelgarn, B. R., Jardine, M. J., Kovesdy, C. P., Kline, G. A., Lindner, G., Obrador, G. T., et al. (2020) · Kidney International · doi:10.1016/j.kint.2019.09.018 · Cited by 498 · see citing works

Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs

Perneger, T. V., Whelton, P. K., & Klag, M. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412223312502 · Cited by 484 · see citing works

Effect of a Mediterranean Diet Supplemented With Nuts on Metabolic Syndrome Status: One-Year Results of the PREDIMED Randomized Trial

Salas-Salvadó, J., Fernández-Ballart, J., Ros, E., Martínez-González, M.-A., Fitó, M., Estruch, R., Corella, D., Fiol, M., Gómez-Gracia, E., Arós, F., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.22.2449 · Cited by 463 · see citing works

Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis

Fletcher, B. R., Damery, S., Aiyegbusi, O. L., Anderson, N., Calvert, M., Cockwell, P., Ferguson, J., Horton, M., Paap, M. C. S., Sidey-Gibbons, C., et al. (2022) · PLOS Medicine · doi:10.1371/journal.pmed.1003954 · Cited by 414 · see citing works

A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate

Goraya, N., Simoni, J., Jo, C.-H., & Wesson, D. E. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02430312 · Cited by 410 · see citing works

Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate

Goraya, N., Simoni, J., Jo, C.-H., & Wesson, D. E. (2014) · Kidney International · doi:10.1038/ki.2014.83 · Cited by 399 · see citing works

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

Writing Group for the CKD Prognosis Consortium, Appel, L. J., Grams, M., Woodward, M., Harris, K., Arima, H., Chalmers, J., Yatsuya, H., Tamakoshi, K., Li, Y., et al. (2023) · JAMA · doi:10.1001/jama.2023.17002 · Cited by 396 · see citing works

Reconsidering the Consequences of Using Race to Estimate Kidney Function

Eneanya, N. D., Yang, W., & Reese, P. P. (2019) · JAMA · doi:10.1001/jama.2019.5774 · Cited by 385 · see citing works

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

(2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30156-5 · Cited by 338 · see citing works

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

Cherney, D. Z. I., Dekkers, C. C. J., Barbour, S. J., Cattran, D., Abdul Gafor, A. H., Greasley, P. J., Laverman, G. D., Lim, S. K., Di Tanna, G. L., Reich, H. N., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30162-5 · Cited by 283 · see citing works

Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: National cohort study

Crump, C., Sundquist, J., Winkleby, M. A., & Sundquist, K. (2019) · BMJ · doi:10.1136/bmj.l1346 · Cited by 265 · see citing works

Long-term evolution of cardiomyopathy in dialysis patients

Foley, R. N., Parfrey, P. S., Kent, G. M., Harnett, J. D., Murray, D. C., & Barre, P. E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00154.x · Cited by 226 · see citing works

Efficacy and safety of evolocumab in chronic kidney disease in the FOURIER trial

Charytan, D. M., Sabatine, M. S., Pedersen, T. R., Im, K., Park, J.-G., Pineda, A. L., Wasserman, S. M., Deedwania, P., Olsson, A. G., Sever, P. S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.513 · Cited by 210 · see citing works

Altered dietary salt intake for people with chronic kidney disease

McMahon, E., Campbell, K., Bauer, J., & Mudge, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010070.pub2 · Cited by 198 · see citing works

The associations of plant protein intake with all-cause mortality in CKD

Chen, X., Wei, G., Jalili, T., Metos, J., Giri, A., Cho, M. E., Boucher, R., Greene, T., & Beddhu, S. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.10.018 · Cited by 187 · see citing works

Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals

Fan, L., Levey, A. S., Gudnason, V., Eiriksdottir, G., Andresdottir, M. B., Gudmundsdottir, H., Indridason, O. S., Palsson, R., Mitchell, G., & Inker, L. A. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014060607 · Cited by 170 · see citing works

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Oshima, M., Jardine, M. J., Agarwal, R., Bakris, G., Cannon, C. P., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Levin, A., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.10.042 · Cited by 166 · see citing works

Prediction and Management of Hyperkalemia Across the Spectrum of Chronic Kidney Disease

Lazich, I., & Bakris, G. L. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.04.008 · Cited by 164 · see citing works

Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium

Shin, J.-I., Chang, A. R., Grams, M. E., Coresh, J., Ballew, S. H., Surapaneni, A., Matsushita, K., Bilo, H. J. G., Carrero, J. J., Chodick, G., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17323 · Cited by 155 · see citing works

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes

Bowman, L., Mafham, M., Stevens, W., Haynes, R., Aung, T., Chen, F., Buck, G., Collins, R., & Armitage, J. (2018) · American Heart Journal · doi:10.1016/j.ahj.2017.12.006 · Cited by 106 · see citing works

International Consensus on Standardized Clinic Blood Pressure Measurement – A Call to Action

Cheung, A. K., Whelton, P. K., Muntner, P., Schutte, A. E., Moran, A. E., Williams, B., Sarafidis, P., Chang, T. I., Daskalopoulou, S. S., Flack, J. M., et al. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.12.015 · Cited by 96 · see citing works

Evaluation of tests for microalbuminuria screening in patients with diabetes

Incerti, J., Zelmanovitz, T., Camargo, J. L., Gross, J. L., & de Azevedo, M. J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi074 · Cited by 93 · see citing works

Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease

Kono, K., Fujii, H., Nakai, K., Goto, S., Shite, J., Hirata, K.-I., Fukagawa, M., & Nishi, S. (2012) · Kidney International · doi:10.1038/ki.2012.118 · Cited by 66 · see citing works

A comparative evaluation of various methods for microalbuminuria screening

Sarafidis, P. A., Riehle, J., Bogojevic, Z., Basta, E., Chugh, A., & Bakris, G. L. (2008) · American Journal of Nephrology · doi:10.1159/000111825 · Cited by 41 · see citing works

Diagnostic Accuracy of Point-of-Care Tests for Detecting Albuminuria: A Systematic Review and Meta-analysis

McTaggart, M. P., Newall, R. G., Hirst, J. A., Bankhead, C. R., Lamb, E. J., Roberts, N. W., & Price, C. P. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2331 · Cited by 39 · see citing works

Cost-Effectiveness of canagliflozin added to standard of care for treating diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM) in England: estimates using the CREDEM-DKD model

Willis, M., Nilsson, A., Kellerborg, K., Ball, P., Roe, R., Traina, S., Beale, R., & Newell, I. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00968-x · Cited by 36 · see citing works

Can a semi-quantitative method replace the current quantitative method for the annual screening of microalbuminuria in patients with diabetes? Diagnostic accuracy and cost-saving analysis considering the potential health burden

Kim, Y., Park, S., Kim, M.-H., Song, S. H., Lee, W. M., Kim, H. S., Jin, K., Han, S., Kim, Y. C., Han, S. S., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227694 · Cited by 12 · see citing works

2018 ESC/ESH Guidelines for the management of arterial hypertension

Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286 · see citing works

Chronic kidney disease

Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842 · see citing works

Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, C. E., Rangaswami, J., Chow, S. L., Neeland, I. J., Tuttle, K. R., Khan, S. S., Coresh, J., Mathew, R. O., Baker-Smith, C. M., Carnethon, M. R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001184 · Cited by 2,208 · see citing works

KDOQI clinical practice guideline for nutrition in CKD: 2020 update

Ikizler, T. A., Burrowes, J. D., Byham-Gray, L. D., Campbell, K. L., Carrero, J.-J., Chan, W., Fouque, D., Friedman, A. N., Ghaddar, S., Goldstein-Fuchs, D. J., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.006 · Cited by 1,960 · see citing works

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.

Perkovic, V., Tuttle, K. R., Rossing, P., Mahaffey, K. W., Mann, J. F. E., Bakris, G., Baeres, F. M. M., Idorn, T., Bosch-Traberg, H., Lausvig, N. L., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2403347 · Cited by 1,849 · see citing works

2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.

Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642 · see citing works

KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease

de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399 · see citing works

KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373 · see citing works

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association

Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001186 · Cited by 1,405 · see citing works

Development and validation of the American Heart Association’s PREVENT equations

Khan, S. S., Matsushita, K., Sang, Y., Ballew, S. H., Grams, M. E., Surapaneni, A., Blaha, M. J., Carson, A. P., Chang, A. R., Ciemins, E., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067626 · Cited by 1,234 · see citing works

Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association

Carnethon, M. R., Pu, J., Howard, G., Albert, M. A., Anderson, C. A. M., Bertoni, A. G., Mujahid, M. S., Palaniappan, L., Taylor, H. A., Willis, M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000534 · Cited by 1,147 · see citing works

Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022) · Diabetes Care · doi:10.2337/dci22-0027 · Cited by 919 · see citing works

The Global Epidemiology of Diabetes and Kidney Disease

Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.10.011 · Cited by 686 · see citing works

Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): A cross-sectional study

Ene-Iordache, B., Perico, N., Bikbov, B., Carminati, S., Remuzzi, A., Perna, A., Islam, N., Bravo, R. F., Aleckovic-Halilovic, M., Zou, H., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)00071-1 · Cited by 627 · see citing works

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

Tuttle, K. R., Lakshmanan, M. C., Rayner, B., Busch, R. S., Zimmermann, A. G., Woodward, D. B., & Botros, F. T. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30104-9 · Cited by 648 · see citing works

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Fulcher, G., Erondu, N., Shaw, W., Barrett, T. D., Weidner-Wells, M., Deng, H., Matthews, D. R., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30141-4 · Cited by 637 · see citing works

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary

Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2019-0472 · Cited by 598 · see citing works

Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency

Levey, A. S., Gansevoort, R. T., Coresh, J., Inker, L. A., Heerspink, H. L., Grams, M. E., Greene, T., Tighiouart, H., Matsushita, K., Ballew, S. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.06.009 · Cited by 591 · see citing works

American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559 · see citing works

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507 · see citing works

Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease

Wanner, C., Lachin, J. M., Inzucchi, S. E., Fitchett, D., Mattheus, M., George, J., Woerle, H. J., Broedl, U. C., von Eynatten, M., & Zinman, B. (2018) · Circulation · doi:10.1161/circulationaha.117.028268 · Cited by 469 · see citing works

NAFLD as a driver of chronic kidney disease

Byrne, C. D., & Targher, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.013 · Cited by 449 · see citing works

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2017 executive summary

Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2017) · Endocrine Practice · doi:10.4158/ep161682.cs · Cited by 435 · see citing works

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Heerspink, H. J. L., Greene, T., Tighiouart, H., Gansevoort, R. T., Coresh, J., Simon, A. L., Chan, T. M., Hou, F. F., Lewis, J. B., Locatelli, F., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30314-0 · Cited by 397 · see citing works

11. Microvascular Complications and Foot Care: <i>Standards of Medical Care in Diabetes—2021</i>

American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s011 · Cited by 395 · see citing works

Social Determinants of Racial Disparities in CKD

Norton, J. M., Moxey-Mims, M. M., Eggers, P. W., Narva, A. S., Star, R. A., Kimmel, P. L., & Rodgers, G. P. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016010027 · Cited by 345 · see citing works

Practical approach to detection and management of chronic kidney disease for the primary care clinician

Vassalotti, J. A., Centor, R., Turner, B. J., Greer, R. C., Choi, M., & Sequist, T. D. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.08.025 · Cited by 291 · see citing works

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2019 executive summary.

Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2019) · Endocrine Practice · doi:10.4158/cs-2018-0535 · Cited by 297 · see citing works

11. Chronic Kidney Disease and Risk Management: <i>Standards of Medical Care in Diabetes—2022</i>

American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s011 · Cited by 344 · see citing works

Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5

Kushner, R. F., Calanna, S., Davies, M., Dicker, D., Garvey, W. T., Goldman, B., Lingvay, I., Thomsen, M., Wadden, T. A., Wharton, S., et al. (2020) · Obesity · doi:10.1002/oby.22794 · Cited by 288 · see citing works

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes

Molitch, M. E., Adler, A. I., Flyvbjerg, A., Nelson, R. G., So, W.-Y., Wanner, C., Kasiske, B. L., Wheeler, D. C., de Zeeuw, D., & Mogensen, C. E. (2015) · Kidney International · doi:10.1038/ki.2014.128 · Cited by 268 · see citing works

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial

Muskiet, M. H. A., Tonneijck, L., Huang, Y., Liu, M., Saremi, A., Heerspink, H. J. L., & van Raalte, D. H. (2018) · The Lancet Diabetes &amp; Endocrinology · doi:10.1016/s2213-8587(18)30268-7 · Cited by 259 · see citing works

Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial

Davies, M. J., Bain, S. C., Atkin, S. L., Rossing, P., Scott, D., Shamkhalova, M. S., Bosch-Traberg, H., Syrén, A., & Umpierrez, G. E. (2016) · Diabetes Care · doi:10.2337/dc14-2883 · Cited by 235 · see citing works

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

Colhoun, H. M., Lingvay, I., Brown, P. M., Deanfield, J., Brown-Frandsen, K., Kahn, S. E., Plutzky, J., Node, K., Parkhomenko, A., Rydén, L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03015-5 · Cited by 238 · see citing works

National Kidney Foundation Laboratory Engagement Working Group recommendations for implementing the CKD-EPI 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories

Miller, W. G., Kaufman, H. W., Levey, A. S., Straseski, J. A., Wilhelms, K. W., Yu, H. Y. (., Klutts, J. S., Hilborne, L. H., Horowitz, G. L., Lieske, J., et al. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvab278 · Cited by 222 · see citing works

Cardiovascular, kidney, and safety outcomes with GLP-1 receptor agonists alone and in combination with SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis

Neuen, B. L., Fletcher, R. A., Heath, L., Perkovic, A., Vaduganathan, M., Badve, S. V., Tuttle, K. R., Pratley, R., Gerstein, H. C., Perkovic, V., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.071689 · Cited by 168 · see citing works

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Oshima, M., Jardine, M. J., Agarwal, R., Bakris, G., Cannon, C. P., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Levin, A., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.10.042 · Cited by 166 · see citing works

Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes

Jiang, G., Luk, A. O. Y., Tam, C. H. T., Xie, F., Carstensen, B., Lau, E. S. H., Lim, C. K. P., Lee, H. M., Ng, A. C. W., Ng, M. C. Y., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.08.026 · Cited by 159 · see citing works

Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium

Shin, J.-I., Chang, A. R., Grams, M. E., Coresh, J., Ballew, S. H., Surapaneni, A., Matsushita, K., Bilo, H. J. G., Carrero, J. J., Chodick, G., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17323 · Cited by 155 · see citing works

Medical Artificial Intelligence and Human Values

Yu, K.-H., Healey, E., Leong, T.-Y., Kohane, I. S., & Manrai, A. K. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2214183 · Cited by 149 · see citing works

Body-mass index and risk of advanced chronic kidney disease: prospective analyses from a primary care cohort of 1.4 million adults in England

Herrington, W. G., Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D. R., Coresh, J., & Woodward, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173515 · Cited by 141 · see citing works

Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial

Pratley, R. E., Tuttle, K. R., Rossing, P., Rasmussen, S., Perkovic, V., Nielsen, O. W., Mann, J. F. E., MacIsaac, R. J., Kosiborod, M. N., Kamenov, Z., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.08.004 · Cited by 132 · see citing works

Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System

Lamprea-Montealegre, J. A., Madden, E., Tummalapalli, S. L., Peralta, C., Neilands, T. B., Garcia, P. K., Muiru, A., Karliner, L., Shlipak, M. G., & Estrella, M. M. (2022) · JAMA · doi:10.1001/jama.2022.13885 · Cited by 129 · see citing works

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Levin, A., Agarwal, R., Herrington, W. G., Heerspink, H. L., Mann, J. F. E., Shahinfar, S., Tuttle, K. R., Donner, J.-A., Jha, V., Nangaku, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.013 · Cited by 125 · see citing works

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Apperloo, E. M., Gorriz, J. L., Soler, M. J., Cigarrán Guldris, S., Cruzado, J. M., Puchades, M. J., López-Martínez, M., Waanders, F., Laverman, G. D., van der Aart-van der Beek, A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03327-6 · Cited by 120 · see citing works

Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies

Colantonio, L. D., Bittner, V., Reynolds, K., Levitan, E. B., Rosenson, R. S., Banach, M., Kent, S. T., Derose, S. F., Zhou, H., Safford, M. M., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.011646 · Cited by 105 · see citing works

Changes in Kidney Function Do Not Differ Between Healthy Adults Consuming Higher-Compared with Lower- or Normal-Protein Diets: A Systematic Review and Meta-Analysis

Devries, M. C., Sithamparapillai, A., Brimble, K. S., Banfield, L., Morton, R. W., & Phillips, S. M. (2018) · The Journal of Nutrition · doi:10.1093/jn/nxy197 · Cited by 108 · see citing works

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment

Yokote, K., Yamashita, S., Arai, H., Araki, E., Suganami, H., & Ishibashi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030706 · Cited by 79 · see citing works

Impact of glucose level on micro- and macrovascular disease in the general population: a Mendelian randomization study

Emanuelsson, F., Marott, S., Tybjærg-Hansen, A., Nordestgaard, B. G., & Benn, M. (2020) · Diabetes Care · doi:10.2337/dc19-1850 · Cited by 59 · see citing works

State of the art for measurement of urine albumin: comparison of routine measurement procedures to isotope dilution tandem mass spectrometry

Bachmann, L. M., Nilsson, G., Bruns, D. E., McQueen, M. J., Lieske, J. C., Zakowski, J. J., & Miller, W. G. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.210302 · Cited by 68 · see citing works

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Beckman, J. A., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108101 · Cited by 64 · see citing works

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome

Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90 · see citing works

Dietary plant and animal protein intake and decline in estimated glomerular filtration rate among elderly women: a 10-year longitudinal cohort study

Bernier-Jean, A., Prince, R. L., Lewis, J. R., Craig, J. C., Hodgson, J. M., Lim, W. H., Teixeira-Pinto, A., & Wong, G. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa081 · Cited by 52 · see citing works

Interventions for weight loss in people with chronic kidney disease who are overweight or obese

Conley, M. M., McFarlane, C. M., Johnson, D. W., Kelly, J. T., Campbell, K. L., & MacLaughlin, H. L. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013119.pub2 · Cited by 49 · see citing works

Changes in albuminuria and subsequent risk of incident kidney disease

Sumida, K., Molnar, M. Z., Potukuchi, P. K., George, K., Thomas, F., Lu, J. L., Yamagata, K., Kalantar-Zadeh, K., & Kovesdy, C. P. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02720317 · Cited by 47 · see citing works

A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease

Selvarajah, V., Robertson, D., Hansen, L., Jermutus, L., Smith, K., Coggi, A., Sánchez, J., Chang, Y.-T., Yu, H., Parkinson, J., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.08.023 · Cited by 49 · see citing works

Albuminuria as a predictor of cardiovascular outcomes in patients with acute myocardial infarction

Mok, Y., Ballew, S. H., Sang, Y., Grams, M. E., Coresh, J., Evans, M., Barany, P., Ärnlöv, J., Carrero, J., & Matsushita, K. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010546 · Cited by 41 · see citing works

Postoperative outcomes among sodium-glucose cotransporter 2 inhibitor users

Tallarico, R. T., Jing, B., Lu, K., Chawla, S. A., Luo, Y., Badathala, A., Chen, C. L., Wallace, A. W., & Legrand, M. (2025) · JAMA Surgery · doi:10.1001/jamasurg.2025.0940 · Cited by 40 · see citing works

Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: A Milestone Achieved

Sarafidis, P., Papadopoulos, C. E., Kamperidis, V., Giannakoulas, G., & Doumas, M. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17005 · Cited by 39 · see citing works

Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial

Kim, C. H., Han, K. A., Yu, J., Lee, S. H., Jeon, H. K., Kim, S. H., Kim, S. Y., Han, K. H., Won, K., Kim, D.-B., et al. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.11.007 · Cited by 36 · see citing works

Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease

Salinero-Fort, M. Á., San Andrés-Rebollo, F. J., de Burgos-Lunar, C., Abánades-Herranz, J. C., Carrillo-de-Santa-Pau, E., Chico-Moraleja, R. M., Jiménez-García, R., López-de-Andrés, A., & Gómez-Campelo, P. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.10.007 · Cited by 35 · see citing works

Diagnostic accuracy of urine dipstick testing for albumin-to-creatinine ratio and albuminuria: a systematic review and meta-analysis

Mejia, J. R., Fernandez-Chinguel, J. E., Dolores-Maldonado, G., Becerra-Chauca, N., Goicochea-Lugo, S., Herrera-Añazco, P., Zafra-Tanaka, J. H., & Taype-Rondan, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08253 · Cited by 35 · see citing works

Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: a 15-year cohort study

Wu, H.-Y., Peng, C.-L., Chen, P.-C., Chiang, C.-K., Chang, C.-J., Huang, J.-W., Peng, Y.-S., Tu, Y.-K., Chu, T.-S., Hung, K.-Y., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177654 · Cited by 33 · see citing works

Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program

Weir, M. R., Slee, A., Sun, T., Balis, D., Oh, R., de Zeeuw, D., & Perkovic, V. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa133 · Cited by 31 · see citing works

SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors

Wing, S., Ray, J. G., Yau, K., Jeyakumar, N., Abdullah, S., Luo, B., Cherney, D. Z. I., Harel, Z., Hundemer, G. L., Mavrakanas, T. A., et al. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.0686 · Cited by 29 · see citing works

Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006–2020

Liaw, J., Harhay, M., Setoguchi, S., Gerhard, T., & Dave, C. V. (2022) · Diabetes Care · doi:10.2337/dc22-0224 · Cited by 21 · see citing works

The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity

Heerspink, H. J. L., Lu, Z., Du, Y., Duffin, K. L., Coskun, T., Haupt, A., & Hartman, M. L. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.03.049 · Cited by 23 · see citing works

Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes

Heerspink, H. J. L., Friedman, A. N., Bjornstad, P., van Raalte, D. H., Cherney, D., Cao, D., Garcia-Pérez, L.-E., Stefanski, A., Turfanda, I., Bunck, M. C., et al. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000764 · Cited by 20 · see citing works

Effectiveness of Empagliflozin vs Dapagliflozin for Kidney Outcomes in Type 2 Diabetes

Bonnesen, K., Heide-Jørgensen, U., Christensen, D. H., Christiansen, C. F., Lash, T. L., Hennessy, S., Matthews, A. A., Pedersen, L., Thomsen, R. W., & Schmidt, M. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.7381 · Cited by 17 · see citing works

Malnutrition and Cachexia in Inpatients With Acute Cardiac Conditions: A Scientific Statement From the American Heart Association

Vest, A. R., DiDomenico, R. J., Lichtenstein, L., Slater, T., Ekpo, E., Damluji, A. A., Bohula, E., Alviar, C. L., on behalf of the American Heart Association Acute Cardiac Care and General Cardiology Committee of the Council on Clinical Cardiology, & Council on Cardiovascular and Stroke Nursing (2026) · Circulation · doi:10.1161/cir.0000000000001405 · Cited by 15 · see citing works

Albuminuria and Prognosis Among Individuals With Atherosclerotic Cardiovascular Disease

Mok, Y., Ballew, S. H., Stacey, R. B., Rossi, J., Koton, S., Kucharska-Newton, A., Chang, P. P., Coresh, J., Rosamond, W., & Matsushita, K. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.089 · Cited by 12 · see citing works

Heat exposure and chronic kidney disease: a temporal link in a Taiwanese agricultural county

Chang, C.-J., Chi, C.-Y., & Yang, H.-Y. (2024) · International Journal of Environmental Health Research · doi:10.1080/09603123.2023.2223514 · Cited by 5 · see citing works

Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement

Kumbhani, D. J., Armbruster, A. L., Cheng, R. K., Chrispin, J., Fischer, U., Holbrook, A. M., Joglar, J., & Sevestre, M.-A. (2026) · JACC · doi:10.1016/j.jacc.2026.05.033 · Cited by 2 · see citing works